Individual and community-level benefits of PrEP in western Kenya and South Africa: Implications for population prioritization of PrEP provision. by Mudimu, Edinah et al.
RESEARCH ARTICLE
Individual and community-level benefits of
PrEP in western Kenya and South Africa:
Implications for population prioritization of
PrEP provision
Edinah MudimuID
1*, Kathryn Peebles2☯, Zindoga Mukandavire3,4☯, Emily NightingaleID5☯,
Monisha Sharma2☯, Graham F. MedleyID
5☯, Daniel J. Klein6, Katharine KripkeID
7☯,
Anna Bershteyn6,8☯
1 Department of Decision Sciences, University of South Africa, Pretoria, South Africa, 2 Department of
Global Health, University of Washington, Seattle, WA, United States of America, 3 Centre for Data Science,
Coventry University, Coventry, United Kingdom, 4 School of Computing, Electronics and Mathematics,
Coventry University, Coventry, United Kingdom, 5 Department of Global Health and Development, London
School of Hygiene and Tropical Medicine, London, United Kingdom, 6 Institute for Disease Modeling, Seattle,
WA, United States of America, 7 Avenir Health, Washington, District of Columbia, United States of America,
8 Department of Population Health, New York University Grossman School of Medicine, NY, United States of
America




Pre-exposure prophylaxis (PrEP) is highly effective in preventing HIV and has the potential
to significantly impact the HIV epidemic. Given limited resources for HIV prevention, identify-
ing PrEP provision strategies that maximize impact is critical.
Methods
We used a stochastic individual-based network model to evaluate the direct (infections pre-
vented among PrEP users) and indirect (infections prevented among non-PrEP users as a
result of PrEP) benefits of PrEP, the person-years of PrEP required to prevent one HIV
infection, and the community-level impact of providing PrEP to populations defined by gen-
der and age in western Kenya and South Africa. We examined sensitivity of results to scale-
up of antiretroviral therapy (ART) and voluntary medical male circumcision (VMMC) by com-
paring two scenarios: maintaining current coverage (“status quo”) and rapid scale-up to
meet programmatic targets (“fast-track”).
Results
The community-level impact of PrEP was greatest among women aged 15–24 due to high
incidence, while PrEP use among men aged 15–24 yielded the highest proportion of indirect
infections prevented in the community. These indirect infections prevented continue to
increase over time (western Kenya: 0.4–5.5 (status quo); 0.4–4.9 (fast-track); South Africa:
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0.5–1.8 (status quo); 0.5–3.0 (fast-track)) relative to direct infections prevented among
PrEP users. The number of person-years of PrEP needed to prevent one HIV infection was
lower (59 western Kenya and 69 in South Africa in the status quo scenario; 201 western
Kenya and 87 in South Africa in the fast-track scenario) when PrEP was provided only to
women compared with only to men over time horizons of up to 5 years, as the indirect bene-
fits of providing PrEP to men accrue in later years.
Conclusions
Providing PrEP to women aged 15–24 prevents the greatest number of HIV infections per
person-year of PrEP, but PrEP provision for young men also provides indirect benefits to
women and to the community overall. This finding supports existing policies that prioritize
PrEP use for young women, while also illuminating the community-level benefits of PrEP
availability for men when resources permit.
Introduction
Sub-Saharan Africa is the region most affected by human immunodeficiency virus (HIV),
accounting for more than 54% of the global population living with HIV [1]. Recent success in
scaling up antiretroviral therapy (ART) coverage in the region has led to substantial declines in
HIV incidence [2]. However, despite these declines, HIV incidence remains high, with approx-
imately 1.1 million new infections in sub-Saharan Africa in 2018 [3], suggesting that additional
HIV prevention methods are required to achieve epidemic control goals.
Oral pre-exposure prophylaxis (PrEP) is a promising HIV prevention method, with efficacy
greater than 90% when used with high adherence [4]. The success of PrEP demonstration proj-
ects [5,6] has led to national scale-up programs in several countries in sub-Saharan Africa,
including Kenya and South Africa. However, costing studies have found PrEP to be a high-
cost form of HIV prevention [7,8]. Providing prevention interventions to people who are most
likely to be infected increases efficiency, and young women, who experience the highest inci-
dence, are likely to benefit the most. However, sexual networks play a key role in determining
how sexually transmitted infections, such as HIV, propagate through communities [9,10].
Consequently, the degree of impact of a prevention intervention such as PrEP also depends on
sexual network characteristics [11]. Providing prevention interventions to individuals with the
highest network connectivity may prevent more total infections for a lower expenditure of
resources [10].
We simulated PrEP provision scenarios using an individual-based network model to com-
pare their impact, individual- and community-level benefits, and number of person-years of
PrEP needed to avert one infection, using western Kenya and South Africa as case studies.
Methods
Model structure
We adapted an existing stochastic agent-based network model, Epidemiological MODeling
software (EMOD) version 2.5, to simulate PrEP delivery for HIV prevention in western Kenya
and South Africa. EMOD is an open-source model for transmission of several high-burden
infectious diseases including HIV, tuberculosis, and malaria [12]. The HIV module, EMOD--
HIV, is available online at https://github.com/InstituteForDiseaseModeling/EMOD alongside
PLOS ONE Individual and community-level benefits of PrEP
PLOS ONE | https://doi.org/10.1371/journal.pone.0244761 December 31, 2020 2 / 11
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: Funding support was provided by the
OPTIONS consortium. The OPTIONS consortium
was made possible by the generous assistance
from the American people through the U.S. Agency
for International Development (USAID) in
partnership with PEPFAR. Financial assistance was
provided by USAID to Avenir Health under the
terms of Cooperative Agreement No. AID-OAA-A-
15-00035. The contents do not necessarily reflect
the views of USAID or the United States
Government. The funder provided support in the
form of salaries for author [KK], but did not have
any additional role in the study design, data
collection and analysis, decision to publish, or
preparation of the manuscript. The specific roles of
these authors are articulated in the ‘author
contributions’ section.
Competing interests: I have read the journal’s
policy and one of the authors of this manuscript
has the following competing interests: KK is
employed by a commercial company: Avenir
Health. This does not alter our adherence to PLOS
ONE policies on sharing data and materials. There
are no patents, products in development or
marketed products to declare.
a detailed model description, parameter definitions, and usage instructions are available at
https://idmod.org/docs/emod/hiv/hiv-model-overview.html. Briefly, the primary mode of
HIV transmission in the model is through a network of relationships categorized into three
types (marital, informal, or transitory) each with different characteristic durations and age/sex
patterns [13]. The networks of relationships are generated by an algorithm that tunes forma-
tion rates by age and sex for each relationship type [14,15]. Transmission risk is applied on a
per-coital-act basis. Mother-to-child transmission is also included and contributes to intergen-
erational transmission [16].
The model was configured to represent South Africa and western Kenya using setting-spe-
cific demography (fertility by age, mortality by age and sex) and parameters with high a priori
uncertainty (e.g., condom usage patterns, rates of concurrent sexual partnerships) were cali-
brated to fit age- and sex-specific HIV prevalence and incidence. We began with previously
published model calibrations for western Kenya [17] and South Africa [18,19] and updated the
calibrations to make use of the most recent available HIV prevalence, incidence, and interven-
tion coverage data. The updated calibration parameters are provided in S2 Appendix S5
Table for western Kenya and S4 Table for South Africa. The final model results for prevalence
of concurrent relationships are similar to published estimates [20]. We calibrated the baseline
and then simulated PrEP scenarios using 250 runs of the stochastic model per scenario.
PrEP parameterization
PrEP was implemented in EMOD-HIV as a reduction to the risk of HIV acquisition per coital
act applicable to those who take up and adhere to PrEP, and time-limited to the period that
these individuals are retained on PrEP [21]. In each model simulation, HIV-negative individu-
als in the selected population groups are eligible to enroll for PrEP. We assumed PrEP effec-
tiveness to be 75% among adherent individuals based on estimates from oral PrEP studies
[22]. PrEP continuation and re-engagement after discontinuation are not well studied. Studies
available have reported high dropout rates [23,24], with many PrEP initiators discontinuing
use after only 30 days [25]. In the United States, PrEP continuation has been reported to last
an average of 14.5 months, with women and young adults (18 to 24 years of age) having the
shortest continuation of approximately 6.9 and 8.6 months, respectively [24]. Based on these
studies, we modelled duration of PrEP use with a Gaussian distribution with a mean of 180
days and a standard deviation of 30 days. We used an optimistic mean duration of 180 days on
PrEP, assuming that future innovations to overcome barriers to PrEP uptake and continuation
in implementation programs in Africa will favour longer durations of PrEP use [26] than cur-
rently observed [27]. Following PrEP discontinuation, we assumed individuals would not re-
initiate PrEP for a minimum of six months. We assumed that PrEP in our model became avail-
able in 2016 for both western Kenya and South Africa, with 45% PrEP coverage among HIV-
negative individuals in the corresponding age/sex category throughout the simulation period.
This high coverage of PrEP provided more stable numbers of individuals on PrEP in our sto-
chastic model, allowing us to evaluate community-level benefits of PrEP.
Model scenarios
We evaluated strategies providing PrEP to different populations defined by age (15–24 and
15–49) and sex (PrEP provided either to women or to men, but never to both). Each PrEP
strategy was evaluated in the context of either a pessimistic (status quo) or optimistic (fast-
track) baseline of ART and male circumcision scale-up (Table 1). The status quo baseline
assumes continuation of current rates of uptake of HIV services (other than PrEP), while the
fast-track baseline assumes achievement of programmatic targets. Specifically, in the fast-track
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baseline, ART coverage is assumed to reach UNAIDS 95-95-95 targets for 2030 [28]. Circum-
cision is assumed to reach South Africa 2017–2021 National Strategic Plan targets [29] and
100,000 cicumcisions yearly from 2022–2036 (to maintain 80% coverage [30]) and in western
Kenya, to achieve 95% coverage among men ages 15–24 years by 2020.
For each PrEP provision strategy, we evaluated the number of HIV infections averted
directly and indirectly by PrEP over a 20-year time horizon. To disentangle the direct (infec-
tions prevented among PrEP users) and indirect (infections prevented among non-PrEP users
as a result of PrEP) effects of PrEP, we calculated the ratio of indirect-to-direct infections
averted, which provides an estimate of the number of indirect infections averted for every one
direct infection averted. We calculated this quantity by first randomizing simulated persons to
receive either placebo or active PrEP. The direct protective effect was then calculated as the dif-
ference between new infections among placebo recipients and active PrEP recipients. The indi-
rect effect was calculated as the difference in total new infections between the counterfactual
simulation (no PrEP in the community) and intervention scenarios, less infections averted by
direct PrEP effects. We also calculated the number of person-years of PrEP required to avert
one infection, regardless of whether the mechanism of protection is direct or indirect.
Results
Averted HIV infections
In the status quo scenario in which ART and male circumcision coverage was maintained at
present-day levels, PrEP use among women yielded the greatest number of total averted infec-
tions (Fig 1) in the initial years of the PrEP program. However, PrEP use among men averted
more infections than PrEP use among women after eight years (in scenarios where PrEP provi-
sion is directed to those aged 15–24) or four years (PrEP to those aged 15–49). In fast-track
scenarios, on the other hand, the greatest number of infections averted is highest when offered
to women over all time horizons, with the exception of the broad age target of individuals aged
14–49 years in South Africa, where there was no difference by gender. In the status quo
Table 1. Status quo and Fast track scenarios and PrEP uptake assumptions.
Scenarios ART Circumcision
Kenya South Africa Kenya South Africa
Status quo 2016 ART uptakea 2015 ART uptakeb 2010–2017 coverage







Efficacy 0.75 Baeten JM et al. 2012 [23]
Coverage 0.45 Assumption
Duration on PrEP Gaussian(180,30) days Assumption
Re-engangement 6 months Assumption
a Kenya 2016 ART uptake guidelines [31].
b South Africa 2015 ART uptake guidelines [32].
c United Nations AIDS. Fast-Track: ending the AIDS epidemic by 2030 [28].
dSouth Africa 2017–2021 National Strategic Plan targets [29].
https://doi.org/10.1371/journal.pone.0244761.t001
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scenarios, infections averted by PrEP continue to increase over time, whereas with concurrent
scale-up of ART and circumcision, the epidemic impact of PrEP is limited to the five-year
period following rollout due to rapid declines in incidence driven by achievement of program-
matic targets in ART and male circumcision coverage.
Indirect-to-direct prevention ratio
The indirect-to-direct prevention ratio was highest when PrEP provision was directed to indi-
viduals aged 15–24 years of age in both western Kenya and South Africa over all time horizons
(Fig 2). Indirect-to-direct ratios increased over time. Providing PrEP to men yielded the high-
est indirect-to-direct ratio (western Kenya: 0.4–5.5 (status quo); 0.4–4.9 (fast-track); range in
South Africa: 0.5–1.8 (status quo); 0.5–3.0 (fast-track)); the first number in the given indirect-
to-direct ratio intervals represent the beginning of the time horizon (2016) and the second
number represent the end of the time horizon (2036). A similar pattern was observed in sce-
narios where PrEP was delivered concurrently with scale-up of ART and circumcision to meet
fast-track targets, though the ratios were lower in the fast-track scenarios.
Number of person-years of PrEP needed to prevent one HIV infection
In status quo scenarios, 59 person-years of PrEP for women aged 15–24 in western Kenya and
69 person-years of PrEP for women aged 15–24 in South Africa were required to avert one
HIV infection over a 5-year timeframe (Fig 3). Over the same time horizon, approximately 94
person-years of PrEP for men in western Kenya and 115 person-years of PrEP for men in
South Africa are required to avert one infection. In western Kenya, the number of person-
years of PrEP needed to avert one infection quadrapled in the fast-track scenario (from 59 to
209 for women and from 94 to 490 for men). In contrast, there was a smaller increase in the
number of person-years of PrEP required to avert one infection in fast-track scenarios in
South Africa (from 69 to 90 for women and from 115 to 120 for men). In both countries, over
Fig 1. Direct prevention and total averted infections compared to status quo and fast-track baseline scenarios in South Africa and a status quo
baseline scenario in Kenya.
https://doi.org/10.1371/journal.pone.0244761.g001
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Fig 2. Indirect-to-direct ratio of infections averted in South Africa and Kenya. Scenarios show results from PrEP provision by age and gender.
https://doi.org/10.1371/journal.pone.0244761.g002
Fig 3. Number of person-years of PrEP needed to prevent one HIV infection by country, baseline scenario, and PrEP provision strategy.
https://doi.org/10.1371/journal.pone.0244761.g003
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5- and 10-year time horizons, giving PrEP to women aged 15–24 required the least resources
to avert one infection. Over a 20-year time horizon in status quo scenarios, the secondary ben-
efits of offering PrEP to men accrue sufficiently that a smaller number of person-years of PrEP
are needed to avert one infection. In fast-track scenarios, offering PrEP to women required
fewer person-years of PrEP to avert one infection across all time horizons in Kenya, and a sim-
ilar number of person-years of PrEP given to men or women were required in South Africa to
avert one infection (Fig 3).
Discussion
We modeled the potential impact of PrEP provision strategies in combination with both status
quo and fast-track scale-up of ART and male circumcision in two countries in sub-Saharan
Africa with varying HIV epidemics. In status quo scenarios in both countries, providing PrEP
to women resulted in the greatest number of HIV infections averted within a 4- to 8-year time
horizon. Long-term impacts (after 8 years from the beginning of PrEP provision) are greater
when providing PrEP to men. However, as countries scale up ART and male circumcision to
meet UNAIDS 95-95-95 targets, our analyses suggest that offering PrEP to women will result
in both the greatest number of infections averted and the lowest person-years of PrEP use per
infection averted. In both status quo and fast-track scenarios, we observed that providing PrEP
to men resulted in the highest indirect-to-direct prevention ratio. This is likely because, in our
model, men have more sexual partners and greater partner concurrency resulting in higher
network connectivity. However, the benefits of providing PrEP to men tended to accrue in
later years, and preventing direct infections in women offered the greatest impact in the first
five years in both status quo and fast-track scenarios. These results were similar in the distinct
epidemiological settings of both Kenya and South Africa, supporting global recommendations
that prioritize PrEP for young women.
We utilized a well-established network model and presented average model results across a
set of 250 simulations per scenario. As the impact of PrEP on the HIV epidemic depends on
the network characteristics of not just the PrEP recipients, but also their partners, and their
partners’ partners, the use of a network-based model allows for realistic estimation of commu-
nity-level health benefits. Previous mathematical modelling [33] demonstrated that earmark-
ing prevention interventions to key population groups like female sex workers can
significantly reduce HIV incidence, but large-scale impact in mature epidemics will require
interventions for both key and non-key populations [34]. Indeed, our analyses showed the
impact for a given set of resources may still be high when directed to a less connected, but
more at-risk, population group, highlighting the importance of providing PrEP to general pop-
ulation groups at elevated risk.
Our study has several limitations. Firstly, PrEP delivery at scale is a relatively recent addition
to the HIV prevention toolkit, and data from real-world settings on key characteristics of PrEP
use are limited. Consequently, we made several simplifying assumptions with respect to PrEP
continuation, re-engagment in care (cycling on and off PrEP), and efficacy. PrEP efficacy was
assumed to be equal between men and women and across age groups. This assumption has a
direct effect on the community-level impact of allocating PrEP to different groups. For example,
allocating PrEP to a group with low adherence would be less effective at the community-level,
including indirect effects in later years. However, although the absolute health benefits of differ-
ent PrEP strategies would change under different assumptions for PrEP efficacy, uptake and
retention, the relative benefits of the strategies should remain the same, with PrEP for women
yielding the greatest number of HIV infections averted. For this reason, we compared extreme
scenarios (provision of PrEP to individuals of just a single age/sex group) to enable comparison
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of the impact of PrEP under each strategy, with the expectation that programs will provide
PrEP to a mix of population groups informed by the impact in each group as well as the accessi-
bility, adherence, and demand for PrEP in each group. Secondly, PrEP enrollment in the model
does not depend on the risk profile of the individuals. In real-world settings, PrEP is recom-
mended to those at substantial risk of acquiring HIV, which includes characteristics such as
having a recent sexually transmitted infection; beliefs about a partner’s HIV status or viral sup-
pression status; residing in a transmission hotspot; or other behavioral, biological, or demo-
graphic indicators of HIV risk. Future work in this area would benefit from detailed modeling
of individual risk profiles to inform PrEP provision strategies at a micro-level. Identifying PrEP
provisions strategies that maximise impact would improve the value proposition of PrEP.
Our analyses evaluated the number of person-years of PrEP required to prevent one HIV
infection as a proxy for the efficiency of providing PrEP to different populations based on sex
and age. Future analyses may extend this work with evaluations of offering PrEP to persons at
substantial risk of HIV acquisiation, regardless of gender or age and evaluations of the eco-
nomic impact and cost-effectiveness of distributing PrEP Primary cost data for exact costs of
PrEP delivery, which may vary based on drug costs and delivery models, is limited [35], with
even less data available on costs of PrEP ancillary services. However, our analysis provides
insight into resource allocation by estimating the community-level impact of different PrEP
provision strategies to identify the strategy with the highest health benefits.
Conclusions
Providing PrEP to women aged 15–24 prevents the greatest number of HIV infections for a
given amount of resources over most time horizons due to women’s higher HIV risk, though
the indirect benefits of providing PrEP to only men were highest across all time points due to
their higher rate of transmission. This finding supports existing policies that prioritize PrEP
provision for young women.
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